Mankind Pharma inks pact with AstraZeneca Pharma India

11 Mar 2024 Evaluate

Mankind Pharma has entered into an agreement with AstraZeneca Pharma India for exclusive distribution of AstraZeneca’s budesonide and formoterol fumarate dihydrate (inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) combination) brand Symbicort in India. AstraZeneca will retain the intellectual property rights to budesonide and formoterol fumarate dihydrate and will continue to be the Marketing Authorisation Holder (MAH) and import license. 

With an expansive distribution network including close to 16,000 field force and more than 13,000 stockists across India, Mankind Pharma has positioned itself as a leader in ensuring availability and access to quality pharmaceuticals across the country, including small towns and rural areas.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.


Mankind Pharma Share Price

2263.15 83.50 (3.83%)
14-May-2024 11:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1540.20
Dr. Reddys Lab 5899.00
Cipla 1372.85
Zydus Lifesciences 987.35
Lupin 1636.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.